Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials.
- DOI
- 10.1007/s10549-023-07147-z
- Published
- 2024 Apr
- Container
- Breast cancer research and treatment
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10549-023-07147-z,
title = {Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials.},
author = {Rugo HS and Van Poznak CH and Neven P and Danielewicz I and Lee SC and Campone M and Chik JYK and Vega Alonso E and Naume B and Brain E and Siegel JM and Li R and Uema D and Wagner VJ and Coleman RE},
year = {2024},
journal = {Breast cancer research and treatment},
doi = {10.1007/s10549-023-07147-z},
url = {https://doi.org/10.1007/s10549-023-07147-z}
}RIS
TY - JOUR TI - Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials. AU - Rugo HS AU - Van Poznak CH AU - Neven P AU - Danielewicz I AU - Lee SC AU - Campone M AU - Chik JYK AU - Vega Alonso E AU - Naume B AU - Brain E AU - Siegel JM AU - Li R AU - Uema D AU - Wagner VJ AU - Coleman RE PY - 2024 JO - Breast cancer research and treatment DO - 10.1007/s10549-023-07147-z UR - https://doi.org/10.1007/s10549-023-07147-z ER -
APA
HS, R., CH, V. P., P, N., I, D., SC, L., M, C., JYK, C., E, V. A., B, N., E, B., JM, S., R, L., D, U., VJ, W., & RE, C. (2024). Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-023-07147-z
Source records
- pubmed · retrieved 2026-09-26T22:59:20.263Z
- europe-pmc · retrieved 2026-09-26T22:59:20.280Z